Consulting

for COVID-19 drug development

14f - Biostats

Service description

The support of R&D projects by experts and specialized firms can be essential in the development of a drug. This enables informed choices to be made more quickly, which is necessary for emergency situations such as those generated by the COVID-19 epidemic.

This service is designed for Biotech companies developing SARS-CoV-2 new drugs.

Materials to provide

  • Details about the project

    Further details on the project may be requested.

You will be able to exchange directly with the experts after filling in the form below.

Typical deliverables

  • Consulting service as validated with the Expert

Get started with your COVID-19 drug development consulting request

Please answer the fields below to be contacted by our team of scientists
section1-3
Back
home